KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Labcorp Holdings (LH) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Labcorp Holdings (LH) over the last 17 years, with Q3 2025 value amounting to $75.5 million.

  • Labcorp Holdings' Tax Provisions rose 8414.63% to $75.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $244.3 million, marking a year-over-year increase of 2730.59%. This contributed to the annual value of $212.4 million for FY2024, which is 1267.9% up from last year.
  • Per Labcorp Holdings' latest filing, its Tax Provisions stood at $75.5 million for Q3 2025, which was up 8414.63% from $66.4 million recorded in Q2 2025.
  • Over the past 5 years, Labcorp Holdings' Tax Provisions peaked at $251.7 million during Q1 2021, and registered a low of -$26.9 million during Q4 2022.
  • Its 5-year average for Tax Provisions is $81.4 million, with a median of $63.9 million in 2023.
  • In the last 5 years, Labcorp Holdings' Tax Provisions skyrocketed by 41158.54% in 2021 and then tumbled by 13572.38% in 2022.
  • Labcorp Holdings' Tax Provisions (Quarter) stood at $75.3 million in 2021, then crashed by 135.72% to -$26.9 million in 2022, then skyrocketed by 173.23% to $19.7 million in 2023, then surged by 104.06% to $40.2 million in 2024, then soared by 87.81% to $75.5 million in 2025.
  • Its Tax Provisions stands at $75.5 million for Q3 2025, versus $66.4 million for Q2 2025 and $62.2 million for Q1 2025.